Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Clinical and Economic Impact of Delayed Reperfusion Therapy: Real-World Evidence.
Gioppatto S, Prado PS, Elias MAL, Carvalho VH, Paiva CRDC, Alexim GA, Reis RTB, Nogueira ACC, Soares AASM, Nadruz W, Carvalho LSF, Sposito AC. Gioppatto S, et al. Among authors: carvalho lsf. Arq Bras Cardiol. 2024 May 13;121(5):e20230650. doi: 10.36660/abc.20230650. eCollection 2024. Arq Bras Cardiol. 2024. PMID: 38747748 Free PMC article. English, Portuguese.
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.
Bonilha I, Gomes ÉIL, Carmo HRP, Breder I, Barreto J, Breder J, Munhoz DB, Carvalho LSF, Quinaglia T, Kimura-Medorima ST, Gossi CM, Zimetti F, Nadruz W, Zanotti I, Sposito AC; EXCEED-BHS3 Group. Bonilha I, et al. Among authors: carvalho lsf. Int J Mol Sci. 2024 Apr 8;25(7):4108. doi: 10.3390/ijms25074108. Int J Mol Sci. 2024. PMID: 38612917 Free PMC article.
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
Nogueira ACC, Barreto J, Moura FA, Luchiari B, Abuhab A, Bonilha I, Nadruz W, Gaziano JM, Gaziano T, de Carvalho LSF, Sposito AC; Brazilian Heart Study Group. Nogueira ACC, et al. Among authors: de carvalho lsf. Health Econ Rev. 2023 Oct 25;13(1):50. doi: 10.1186/s13561-023-00466-3. Health Econ Rev. 2023. PMID: 37878108 Free PMC article.
Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis.
Pugliesi A, de Oliveira AB, Oliveira AB, Xavier R, da Mota LMH, Bertolo MB, Gonzalez-Gay MA, Citera G, de Carvalho LSF. Pugliesi A, et al. Among authors: de carvalho lsf. Adv Rheumatol. 2023 Jul 6;63(1):30. doi: 10.1186/s42358-023-00298-z. Adv Rheumatol. 2023. PMID: 37415193
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19.
Carmo HRP, Yoshinaga MY, Castillo AR, Britto Chaves-Filho A, Bonilha I, Barreto J, Muraro SP, de Souza GF, Davanzo GG, Perroud MW Jr, Lukhna K, Ntsekhe M, Davidson S, Velloso LA, Nadruz W, Carvalho LSF, Sáinz-Jaspeado M, Farias AS, Proença-Módena JL, Moraes-Vieira PM, Karathanasis SK, Yellon D, Miyamoto S, Remaley AT, Sposito AC. Carmo HRP, et al. Among authors: carvalho lsf. Mol Genet Metab. 2023 Apr;138(4):107552. doi: 10.1016/j.ymgme.2023.107552. Epub 2023 Feb 27. Mol Genet Metab. 2023. PMID: 36889041 Free PMC article.
71 results